NOVARTINDUpdated 1 Sept 2026, 1:51

Novartis India Limited

NOVARTINDUpdated 1 Sept 2026, 1:51

Market Cap

₹3,837Cr.

Current Price

₹1,554

High / Low

₹1,780/750

Stock P/E

39.2

ROE11.6%

ROCE16.2%

Book Value₹331

Face Value₹5.00

Dividend Yield1.61%

About

Novartis India Ltd is primarily engaged in the Business of Wholesale of pharmaceuticals and medical goods.[1]It imports various medicines to India from different sources across the globe.[2]

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Jul 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	35	27	23	28	34	31	37	41	35	45	41	38
Inventory Days	103	92	104	84	111	117	119	117	99	82	74	98
Days Payable	98	89	87	158	168	145	137	148	108	112	93	101
Cash Conversion Cycle	40	30	40	-45	-23	3	19	10	26	15	22	36
Working Capital Days	6	-35	-14	-99	7	-1	62	-23	-37	-59	-45	-46
ROCE %	9%	22%	9%	17%	12%	5%	6%	6%	15%	16%	17%	16%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 1 September 2026 at 1:51

NOVARTIS INDIA LIMITED (NOVARTIND) financials — quarterly results, P&L, cash flow, balance sheet, shareholding